BioCentury
ARTICLE | Clinical News

Escagenetics regulatory update

October 18, 1993 7:00 AM UTC

ESCAgenetics Corp. (ESN) ESN received notice of allowance of a U.S. Patent covering the use of bacteria to induce formation of cell masses (galls) on stems of any member of the genus Taxus. ESN said ...